KSM Feed

More asthma sufferers live in areas with high levels of pollution

For World Asthma Day, we examined air quality ratios in various geographic locations in Israel, and the prevalence of Asthma...

BioBank and Genetic Research: Dr. Tal Patalon, Head of KSM, discusses these topics on Kan Radio.

KSM research on natural immunity.

Globes: Monkeypox – Dr. Tal Patalon explaination her view.

Monkeypox in a developing country: A Case Report.

Delta reinfection risk low among unvaccinated children.

KSM study: Immunity against COVID-19 among children many months after infection.

Our new study on the duration of protection conferred by a previous SARS-CoV-2 infection amongst children and adolescents.

Our new COVID-19 4th shot study continues to make headlines.

Our Deputy Head Dr. Sivan Gazit on Channel 13 evening news.

The 4th dose of the BNT162b2 vaccine provides at least 73% protection against SARS-CoV-2 severe illness relative to three doses.

82% decreased risk of reinfection among persons who were infected and then vaccinated.

Association of BNT162b2 COVID-19 Vaccination During Pregnancy With Neonatal and Early Infant Outcomes.

Dr. Sivan Gazit, Deputy Head of KSM, was chosen by TheMarker as one of the most promising leaders under 40.